发明名称 HLA binding peptides and their uses
摘要 The present invention provides the means and methods for selecting immunogenic peptides and the immunogenic peptide compositions capable of specifically binding glycoproteins encoded by HLA alleles and inducing T cell activation in T cells restricted by the allele. The peptides are useful to elicit an immune response against a desired antigen. The immunogenic peptide compositions of the present invention comprise immunogenic peptides having an HLA binding motif, where the peptide is from a target antigen. Target antigens of the present invention include prostate specific antigen (PSA), hepatitis B core and surface antigens (HBVc, HBVs) hepatitis C antigens, Epstein-Barr virus antigens, melanoma antigens (e.g., MAGE-1), human immunodeficiency virus (HIV) antigens, human papilloma virus (HPV) antigens, Lassa virus, mycobacterium tuberculosis (MT), p53, CEA, trypanosome surface antigen (TSA) and Her2/neu. An example of an immunogenic peptide of the present invention corresponds to a peptide less than about 15 amino acids in length that comprises an HLA-A2.1 binding motif, where the peptide comprises the p53 sequence SMPPPGTRV.
申请公布号 US7252829(B1) 申请公布日期 2007.08.07
申请号 US19980189702 申请日期 1998.11.10
申请人 IDM PHARMA, INC. 发明人 SETTE ALESSANDRO;SIDNEY JOHN;SOUTHWOOD SCOTT;CELIS ESTEBAN
分类号 A61K38/08;A61K38/00;A61K38/10;A61K39/00;C07K4/12;C07K14/02;C07K14/18;C07K14/74 主分类号 A61K38/08
代理机构 代理人
主权项
地址